Hertraz Injection

✅ Targets HER2-positive tumors
✅ Inhibits cancer cell growth
✅ Reduces tumor recurrence
✅ Enhances survival rates
✅ Improves treatment outcomes

Hertraz Injection contains Trastuzumab.

SKU: N/A Kategori: Kreftmedisin, Kategorioversikt, Kroniske tilstander Stikkord: Hertraz Injection, Trastuzumab

✓ Medisinsk vurdert av Morgan Ellis — Farmasøytisk forsker · 8 års erfaring · Sist gjennomgått: mai 2026

Kryptert betaling

Krypto betaling gir 10% rabatt

Diskret levering over hele verden

1.400+ kunder · 50+ land

Kort svar

Hertraz Injection is specialist-supervised oncology agent — administered under hospital supervision. Read the dosing, side-effect, and interaction sections below before use; the FAQs at the bottom cover the most common questions.

Hva du får med MedsBase: WHO-GMP-sertifisert produsent · Diskret emballasje · Verdensomspennende levering · 1 400+ verifiserte kundeanmeldelser

📦 Hver ordre er dekket av vår Reshipment Assurance Policy — hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.

Hvorfor bestille fra MedsBase

Våre generiske legemidler kommer fra WHO-GMP-sertifiserte produsenter og sendes over hele verden i diskret, nøytral emballasje — ingen legemiddelnavn på utsiden av pakken. Kortbetalinger håndteres av en regulert betalingsbehandler (kontoutskrifter viser en regulert kortbetalingsprosessor — aldri “MedsBase” eller noe legemiddelnavn). Krypto og SEPA bankoverførsel godtas også. Hver ordre er dekket av vår Reshipment Assurance Policy.

Produktoppsummering

Hertraz Injection is a medication containing the active ingredient Trastuzumab, available in vial form with a concentration of 440mg per vial. Trastuzumab is a monoclonal antibody used in the treatment of certain types of cancer, including breast cancer and gastric cancer. It is a targeted therapy that works by binding to specific receptors on cancer cells, inhibiting their growth and promoting cell death. Hertraz Injection is administered intravenously under the supervision of a healthcare professional.

Bruk

Hertraz Injection is indicated for the treatment of HER2-positive breast cancer, either alone or in combination with other chemotherapy agents. It is also used in combination with other drugs to treat HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. HER2-positive cancers overexpress the human epidermal growth factor receptor 2 (HER2), and Trastuzumab specifically targets these receptors to inhibit cancer cell proliferation.

Bruk anvisning

Hertraz Injection is administered as an intravenous infusion by a healthcare provider in a clinical setting. The dosage and infusion rate are determined based on the patient’s body weight and medical condition. Prior to administration, the vial should be inspected visually for any particulate matter or discoloration. The injection should be given over a specified period, and patients are monitored for any signs of infusion-related reactions during and after the infusion.

Virkemåte

Trastuzumab, the active ingredient in Hertraz Injection, is a monoclonal antibody that targets and binds to the HER2 receptors present on the surface of cancer cells. By binding to these receptors, Trastuzumab inhibits downstream signaling pathways that promote cell proliferation and survival. Additionally, it can stimulate the immune system to attack HER2-positive cancer cells, further enhancing its anticancer effects. This targeted approach helps to selectively destroy cancer cells while minimizing damage to healthy tissues.

Dosering og administrering

The recommended dosage of Hertraz Injection varies depending on the type and stage of cancer being treated, as well as other factors such as the patient’s weight and overall health. It is typically administered intravenously every 1 to 3 weeks, with the dosage adjusted based on the patient’s tolerance and response to treatment. Treatment duration may vary, and patients should follow the dosing schedule recommended by their healthcare provider.

Fordeler

Effective in the treatment of HER2-positive breast cancer and gastric cancer
Targeted therapy with minimal impact on healthy cells
Can be used alone or in combination with other chemotherapy agents
May improve overall survival and reduce the risk of cancer recurrence
Well-tolerated with manageable side effects compared to traditional chemotherapy

Vanlige bivirkninger

Common side effects of Hertraz Injection may include infusion-related reactions, such as fever, chills, nausea, vomiting, headache, fatigue, and allergic reactions. Some patients may experience cardiotoxicity, manifested as decreased heart function or heart failure, and monitoring of cardiac function is recommended during treatment.

Advarsler

Patients receiving Hertraz Injection should be monitored closely for signs of cardiac toxicity, particularly those with pre-existing heart conditions or a history of cardiac dysfunction. The medication should be used with caution in pregnant or breastfeeding women, as it may harm the developing fetus or nursing infant. Prior to initiation of treatment, patients should undergo thorough cardiac evaluation, and concomitant use with anthracycline-based chemotherapy should be avoided due to increased risk of cardiotoxicity.

Oppbevaringsinformasjon

Hertraz Injection should be stored in its original packaging at controlled room temperature, away from light and moisture. The vials should be protected from freezing and kept out of the reach of children and pets. Unused portions of the medication should be discarded properly according to local regulations.

Ansvarsfraskrivelse:

Vår eneste hensikt er å sikre at forbrukerne får informasjon som er fagfellevurdert, nøyaktig og pålitelig. Imidlertid bør ikke informasjonen her brukes som erstatning for råd fra en kvalifisert lege. Informasjonen som gis her er kun til informasjonsformål. Den dekker kanskje ikke alle mulige bivirkninger, legemiddelinteraksjoner eller advarsler. Vennligst konsulter legen din og diskuter alle spørsmål du har relatert til sykdom eller medisin. Vi ønsker å støtte, ikke erstatte, lege-pasient-forholdet.

Vanlige spørsmål

How does Hertraz Injection work?

Hertraz Injection is a specialist oncology agent — refer to the prescribing centre's treatment protocol for the specific indication, dose, and cycle. The mechanism, dose-by-indication tables, and contraindication list above give the molecule-specific clinical detail.

How quickly does Hertraz Injection work?

treatment cycles are individualised; response is monitored on imaging, blood markers, and clinical assessment per protocol. Read the indication-specific dosing section above for the schedule that applies to your case.

Hva er de vanligste bivirkningene?

Bivirkningsprofilen avhenger av molekylet og dosen. Den kliniske delen ovenfor lister opp de hyppige, tilfeldige og sjeldne bivirkningene du kan forvente, pluss advarselstegn som krever umiddelbar medisinsk vurdering.

Can I take Hertraz Injection with food or alcohol?

Interaksjoner med mat og alkohol varierer avhengig av molekylet. Sjekk tabellen over legemiddelinteraksjoner ovenfor for spesifikke regler som gjelder for mat, alkohol og samtidig bruk av andre legemidler.

Hva bør jeg gjøre hvis jeg glemmer en dose?

Vanligvis bør du ta en glemt dose så snart du husker det, med mindre det er nær tid for neste planlagte dose. I så fall hopper du over den glemte dosen – aldri ta en dobbel dose. Spesifikke molekyler har spesifikke regler; doseringsdelen ovenfor angir om dette legemidlet har noen ikke-standard håndtering av glemte doser.

Where can I order Hertraz Injection from MedsBase?

MedsBase ships Hertraz Injection discreetly worldwide from a WHO-GMP certified manufacturer. Card payments are processed through a regulated crypto on-ramp — your bank statement shows the processor name (a regulated card-payment processor), never “MedsBase” or any medication name. Every order is covered by our 20-business-day Reshipment Assurance.